SARS-CoV-2: Targeted managements and vaccine development

M Bakhiet, S Taurin - Cytokine & growth factor reviews, 2021 - Elsevier
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …

[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2

JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …

[HTML][HTML] An updated review of SARS-CoV-2 vaccines and the importance of effective vaccination programs in pandemic times

C García-Montero, O Fraile-Martínez, C Bravo… - Vaccines, 2021 - mdpi.com
Since the worldwide COVID-19 pandemic was declared a year ago, the search for vaccines
has become the top priority in order to restore normalcy after 2.5 million deaths worldwide …

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson

R Patel, M Kaki, VS Potluri, P Kahar… - Human vaccines & …, 2022 - Taylor & Francis
The novel coronavirus outbreak was declared a pandemic in March 2020. We are reviewing
the COVID-19 vaccines authorized for use in the United States by discussing the …

[HTML][HTML] The 2020 pandemic: current SARS-CoV-2 vaccine development

SO Alturki, SO Alturki, J Connors, G Cusimano… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome
infecting animals and humans. Coronaviruses have been described more than 70 years ago …

[HTML][HTML] SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

S Chakraborty, V Mallajosyula, CM Tato, GS Tan… - Advanced drug delivery …, 2021 - Elsevier
The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and
scientific expertise toward the goal of developing investigational vaccines to prevent COVID …

[HTML][HTML] The SARS-CoV-2 vaccine pipeline: an overview

WH Chen, U Strych, PJ Hotez, ME Bottazzi - Current tropical medicine …, 2020 - Springer
Each current vaccine strategy has distinct advantages and disadvantages. Therefore, it is
paramount that multiple strategies be advanced quickly and then evaluated for safety and …

[HTML][HTML] Current clinical trials protocols and the global effort for immunization against SARS-CoV-2

GNA Rego, MP Nucci, AH Alves, FA Oliveira, LC Marti… - Vaccines, 2020 - mdpi.com
Coronavirus disease 2019 (COVID-19) is the biggest health challenge of the 21st century,
affecting millions of people globally. The outbreak of severe acute respiratory syndrome …

[HTML][HTML] Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines

KL Flanagan, E Best, NW Crawford, M Giles… - Frontiers in …, 2020 - frontiersin.org
There are currently around 200 SARS-CoV-2 candidate vaccines in preclinical and clinical
trials throughout the world. The various candidates employ a range of vaccine strategies …

SARS-CoV-2 vaccine development: an overview and perspectives

Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …